Literature DB >> 27165151

Approaches for modeling within subject variability in pharmacometric count data analysis: dynamic inter-occasion variability and stochastic differential equations.

Chenhui Deng1,2, Elodie L Plan3, Mats O Karlsson3.   

Abstract

Parameter variation in pharmacometric analysis studies can be characterized as within subject parameter variability (WSV) in pharmacometric models. WSV has previously been successfully modeled using inter-occasion variability (IOV), but also stochastic differential equations (SDEs). In this study, two approaches, dynamic inter-occasion variability (dIOV) and adapted stochastic differential equations, were proposed to investigate WSV in pharmacometric count data analysis. These approaches were applied to published count models for seizure counts and Likert pain scores. Both approaches improved the model fits significantly. In addition, stochastic simulation and estimation were used to explore further the capability of the two approaches to diagnose and improve models where existing WSV is not recognized. The results of simulations confirmed the gain in introducing WSV as dIOV and SDEs when parameters vary randomly over time. Further, the approaches were also informative as diagnostics of model misspecification, when parameters changed systematically over time but this was not recognized in the structural model. The proposed approaches in this study offer strategies to characterize WSV and are not restricted to count data.

Entities:  

Keywords:  Count data; Dynamic inter-occasion variability; Stochastic differential equations; Within subject variability

Mesh:

Year:  2016        PMID: 27165151     DOI: 10.1007/s10928-016-9473-1

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  14 in total

1.  Grey-box pharmacokinetic/pharmacodynamic modelling of a euglycaemic clamp study.

Authors:  Christoffer Wenzel Tornøe; Judith L Jacobsen; Henrik Madsen
Journal:  J Math Biol       Date:  2003-12-02       Impact factor: 2.259

2.  Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysis.

Authors:  Ulrika Wählby; Alison H Thomson; Peter A Milligan; Mats O Karlsson
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

3.  PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

Authors:  Lars Lindbom; Pontus Pihlgren; E Niclas Jonsson; Niclas Jonsson
Journal:  Comput Methods Programs Biomed       Date:  2005-09       Impact factor: 5.428

4.  Likert pain score modeling: a Markov integer model and an autoregressive continuous model.

Authors:  E L Plan; J-P Elshoff; A Stockis; M L Sargentini-Maier; M O Karlsson
Journal:  Clin Pharmacol Ther       Date:  2012-03-21       Impact factor: 6.875

5.  The importance of modeling interoccasion variability in population pharmacokinetic analyses.

Authors:  M O Karlsson; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1993-12

6.  Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic-pituitary-gonadal axis following treatment with GnRH analogues.

Authors:  Christoffer W Tornøe; Henrik Agersø; Thomas Senderovitz; Henrik A Nielsen; Henrik Madsen; Mats O Karlsson; E Niclas Jonsson
Journal:  Br J Clin Pharmacol       Date:  2006-11-10       Impact factor: 4.335

7.  Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations.

Authors:  Christoffer W Tornøe; Rune V Overgaard; Henrik Agersø; Henrik A Nielsen; Henrik Madsen; E Niclas Jonsson
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

8.  Pharmacokinetic/pharmacodynamic modeling of luteinizing hormone (LH) suppression and LH surge delay by cetrorelix after single and multiple doses in healthy premenopausal women.

Authors:  Nelamangala V Nagaraja; Birgit Pechstein; Katharina Erb; Christine Klipping; Robert Hermann; Mathias Locher; Hartmut Derendorf
Journal:  J Clin Pharmacol       Date:  2003-03       Impact factor: 3.126

9.  Modelling overdispersion and Markovian features in count data.

Authors:  Iñaki F Trocóniz; Elodie L Plan; Raymond Miller; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-10-02       Impact factor: 2.745

10.  Modeling and simulation of count data.

Authors:  E L Plan
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-08-13
View more
  6 in total

1.  Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data.

Authors:  João A Abrantes; Siv Jönsson; Mats O Karlsson; Elisabet I Nielsen
Journal:  Br J Clin Pharmacol       Date:  2019-04-29       Impact factor: 4.335

2.  Exact Gradients Improve Parameter Estimation in Nonlinear Mixed Effects Models with Stochastic Dynamics.

Authors:  Helga Kristin Olafsdottir; Jacob Leander; Joachim Almquist; Mats Jirstrand
Journal:  AAPS J       Date:  2018-08-01       Impact factor: 4.009

3.  Pharmacometrics models with hidden Markovian dynamics.

Authors:  Marc Lavielle
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-08-31       Impact factor: 2.745

4.  A big data approach to the development of mixed-effects models for seizure count data.

Authors:  Joseph J Tharayil; Sharon Chiang; Robert Moss; John M Stern; William H Theodore; Daniel M Goldenholz
Journal:  Epilepsia       Date:  2017-03-30       Impact factor: 5.864

5.  Optimising infliximab induction dosing for patients with ulcerative colitis.

Authors:  Erwin Dreesen; Ruben Faelens; Gert Van Assche; Marc Ferrante; Séverine Vermeire; Ann Gils; Thomas Bouillon
Journal:  Br J Clin Pharmacol       Date:  2019-02-10       Impact factor: 4.335

6.  Natural variability in seizure frequency: Implications for trials and placebo.

Authors:  Juan Romero; Phil Larimer; Bernard Chang; Shira R Goldenholz; Daniel M Goldenholz
Journal:  Epilepsy Res       Date:  2020-03-06       Impact factor: 3.045

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.